JOHNSON JOHN

CIK 00014107817 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001410781

Recent Transactions

43 trades

Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-06-04+50,000→ 940,983 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-06-04+50,000→ 940,983 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-06-05+50,000→ 890,983 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-06-05+50,000→ 890,983 total
Exercise/Conversion
Axogen, Inc.$AXGN
Restricted Stock Units
2023-06-01−6,459→ 0 total
Exercise/Conversion
Axogen, Inc.$AXGN
Common Stock
2023-06-01+6,459→ 6,459 total
Exercise/Conversion
Axogen, Inc.$AXGN
Restricted Stock Units
2023-06-01−6,459→ 0 total
Exercise/Conversion
Axogen, Inc.$AXGN
Common Stock
2023-06-01+6,459→ 6,459 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock
2016-06-02+9,800→ 9,800 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock
2016-06-02+9,800→ 9,800 total
Award
MELINTA THERAPEUTICS, INC. /NEW/
Stock Option (Right to Buy)
2016-01-01+15,000→ 15,000 total
Award
MELINTA THERAPEUTICS, INC. /NEW/
Stock Option (Right to Buy)
2016-01-01+15,000→ 15,000 total
Award
MELINTA THERAPEUTICS, INC. /NEW/
Stock Option (Right to Buy)
2015-01-01+15,000→ 15,000 total
Award
MELINTA THERAPEUTICS, INC. /NEW/
Stock Option (Right to Buy)
2015-01-01+15,000→ 15,000 total
Award
DENDREON CORP
Common Stock
2014-01-03+395,189→ 1,084,812 total
Tax Payment
DENDREON CORP
Common Stock
2014-01-03$3.08/sh−35,796→ 1,049,016 total
Award
DENDREON CORP
Common Stock
2014-01-03+395,189→ 1,084,812 total
Tax Payment
DENDREON CORP
Common Stock
2014-01-03$3.08/sh−35,796→ 1,049,016 total
Tax Payment
DENDREON CORP
Common Stock
2013-12-31$2.99/sh−38,382→ 689,623 total
Tax Payment
DENDREON CORP
Common Stock
2013-12-31$2.99/sh−38,382→ 689,623 total
Tax Payment
DENDREON CORP
Common Stock
2012-12-31$5.29/sh−40,342→ 332,816 total
Award
DENDREON CORP
Common Stock
2012-01-03+25,000→ 37,943 total
Sale
SAVIENT PHARMACEUTICALS INC
Common Stock, $.01 par value per share
2012-01-03$2.30/sh−17,650→ 252,350 total
Sale
SAVIENT PHARMACEUTICALS INC
Common Stock, $.01 par value per share
2012-01-03$2.30/sh−17,650→ 252,350 total
Award
DENDREON CORP
Common Stock
2012-01-03+25,000→ 37,943 total
Purchase
SAVIENT PHARMACEUTICALS INC
Common Stock, $.01 par value per share
2011-11-18$2.36/sh+1,000→ 4,000 total
Purchase
SAVIENT PHARMACEUTICALS INC
Common Stock, $.01 par value per share
2011-11-18$2.28/sh+10,000→ 265,000 total
Award
IMCLONE SYSTEMS INC
Restricted Stock Unit
2007-08-27+7,837→ 15,674 total
Award
IMCLONE SYSTEMS INC
Stock Options (Right to Buy)
2007-08-27+87,500→ 262,500 total
Award
IMCLONE SYSTEMS INC
Restricted Stock Unit
2007-08-27+7,837→ 7,837 total
Award
IMCLONE SYSTEMS INC
Restricted Stock Unit
2007-08-27+7,836→ 31,347 total
Award
IMCLONE SYSTEMS INC
Restricted Stock Unit
2007-08-27+7,837→ 23,511 total
Award
IMCLONE SYSTEMS INC
Stock Options (Right to Buy)
2007-08-27+87,500→ 175,000 total
Award
IMCLONE SYSTEMS INC
Stock Options (Right to Buy)
2007-08-27+87,500→ 350,000 total
Award
IMCLONE SYSTEMS INC
Stock Options (Right to Buy)
2007-08-27+87,500→ 87,500 total
Award
IMCLONE SYSTEMS INC
Stock Options (Right to Buy)
2007-08-27+87,500→ 350,000 total
Award
IMCLONE SYSTEMS INC
Stock Options (Right to Buy)
2007-08-27+87,500→ 87,500 total
Award
IMCLONE SYSTEMS INC
Restricted Stock Unit
2007-08-27+7,836→ 31,347 total
Award
IMCLONE SYSTEMS INC
Stock Options (Right to Buy)
2007-08-27+87,500→ 262,500 total
Award
IMCLONE SYSTEMS INC
Stock Options (Right to Buy)
2007-08-27+87,500→ 175,000 total
Award
IMCLONE SYSTEMS INC
Restricted Stock Unit
2007-08-27+7,837→ 15,674 total
Award
IMCLONE SYSTEMS INC
Restricted Stock Unit
2007-08-27+7,837→ 23,511 total
Award
IMCLONE SYSTEMS INC
Restricted Stock Unit
2007-08-27+7,837→ 7,837 total

Companies

Recent Filings

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607

View on SEC.gov